Key result
Remimazolam at /kg optimizes sedation depth over lower doses while better preserving cardiac output.
Why the study?
The study evaluated the effects of different intravenous induction doses of remimazolam besylate on sedation quality and cardiac function in elderly patients.
Does a middle (0.3 mg/kg) or high (0.4 mg/kg) induction dose of intravenous remimazolam besylate improve the quality of sedation and maintain better cardiac function compared to a low dose (0.2 mg/kg) in elderly patients undergoing laparoscopic cholecystectomy?
RCT (n=135)
Double-blind
random number method
No
Does a middle (0.3 mg/kg) or high (0.4 mg/kg) induction dose of intravenous remimazolam besylate improve the quality of sedation and maintain better cardiac function compared to a low dose (0.2 mg/kg) in elderly patients undergoing laparoscopic cholecystectomy?
An induction dose of remimazolam besylate at 0.3 mg/kg provides a rapid and optimal depth of sedation while preserving hemodynamic stability and cardiac function in elderly surgical patients.
Answers are grounded in this paper and cite their sources.
0.3 mg/kg remimazolam may optimize sedation with preserved cardiac output in elderly patients; extends RCT dosing evidence for this agent.
Background We intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients. Methods A total of 135 ASA I–III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T 0 ), after induction (T 1 ) and after intubation (T 2 ), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded. Results At T 1 and T 2 , systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences ( P < 0.05). At T 1 and T 2 , the BIS value in Group M was lower than that in Group L, with a statistically significant difference ( P < 0.05). However, there was no statistically significant difference ( P > 0 . 05) in BIS values between Group M and Group H; At T 1 and T 2 , the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences ( P < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences ( P < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences ( P < 0.05). Conclusions General anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.
No takes yet. Share an insight, caveat, or question.
Minghong et al. (2025) conducted an RCT in Elective laparoscopic cholecystectomy (ASA I-III) (n=135). Remimazolam besylate vs. Remimazolam besylate 0.2 mg/kg (Group L) was evaluated on Quality of sedation (BIS values) and cardiac function (cardiac output, stroke volume, systemic vascular resistance) after induction and intubation (p=<0.05). Remimazolam besylate induction at /kg provided better sedation depth than /kg and maintained higher cardiac output and stroke volume compared to /kg.
Synapse has enriched 10 related papers. Consider them for comparative context: